secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alaunos Therapeutics, Inc. (TCRT)
CIK:        0001107421
Form:       8-K
Filed at:   2025-06-26T23:59:59+00:00
Accession:  0000950170-25-090201
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alaunos Therapeutics raises $850K via private placement of Series A-2 Convertible Preferred Stock
--------------------------------------------------------------------------------

- Aggregate purchase price of $850,000 from accredited investors; offering closed June 24, 2025.
- Each Series A-2 Preferred share priced at $1,000, convertible into common at $4.49 per share.
- Preferred stock carries 10% annual dividend payable in additional Preferred shares.
- Shares issued under Section 4(a)(2) and/or Rule 506(b), are restricted and not registered under Securities Act.
- 1,000 Series A-2 shares designated; 1,639,521 common shares outstanding prior to the offering.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1107421/000095017025090201/0000950170-25-090201-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1107421/000095017025090201/tcrt-20250624.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-090201

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer